Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Nerve Block Trays and Needles

Active
MW-2109-53Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract modification serves to notify qualified entities about the release of a Qualified Suppliers List (QSL) for nerve block needles under solicitation number MW-2111-58. This announcement is part of a presolicitation process led by the Defense Logistics Agency Troop Support, specifically for nerve block trays and needles. The solicitation was initially posted on March 17, 2022, under NAICS code 339113, which relates to medical equipment manufacturing. All relevant solicitation details are accessible through the System for Award Management (SAM) website, ensuring transparency and ease of access for interested suppliers. The performance location for this contract is Frederick, Maryland, while the contracting office is based in Philadelphia, Pennsylvania. The point of contact for inquiries includes Tara J. Perrien, Contracting Officer, as well as the MMESO Enterprise Wide Standardization team, who can provide further assistance through designated email addresses. This presolicitation encourages qualified suppliers to prepare for participation in the upcoming procurement opportunity with the Department of Defense, emphasizing the importance of submitting interest via the official SAM platform.

General Info

Qualified suppliers notified of nerve block needles QSL release under DoD solicitation MW-2111-58.

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

Frederick, MD, 21702, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

1 update
PhasePresolicitation
Posted

Presolicitation

Notice updated

The notice description changed.

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts2 people available
OfficePHILADELPHIA, PA, 19111, USA
Office AddressPHILADELPHIA, PA, 19111, USA
Contacts
Tara J. Perrien Contracting Officer
MMESO Enterprise Wide Standardization

Full Description

Show more
The purpose of this modification to the Notice of Intent (NOI)/Presolicitation to establish a QSL is to inform qualified entities interested in providing these services that the release of the QSL Announcement for MW-2111-58 Nerve Block Needles, has been issued. All solicitation information is available electronically on the System for Award Management (SAM) website.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

NAICS: 326199
New
Federal
Synopsis for Outserts (NSN - 4240-01-529-8327 & 4240-01-528-9288)
Solicitation # 015298327_015289288
Solicitation SPE8EG-26-R-0003 is an unrestricted, fixed-price with economic price adjustment, indefinite delivery/indefinite quantity contract issued by DLA Troop Support. The procurement is for critical Chemical Biological Radiation and Nuclear Personal Protective Equipment, specifically Clear Assembly Outserts (NSN 4240-01-529-8327) and Laser Assembly Outserts (NSN 4240-01-528-9288). The contract structure consists of a one-year base period and four one-year option periods, with a target delivery schedule of 100 days and terms set as FOB Origin. Avon Protection Systems Incorporated is the approved source, and while alternate offers are encouraged via specific DLAD procurement notes, they require a complete data package for evaluation. The solicitation has undergone five amendments, with the final closing date extended to September 2, 2026, at 3:00 PM EDT. Key regulatory requirements include compliance with the Buy American Act, the Berry Amendment, and export-control regulations under ITAR and EAR, requiring offerors to have approved US/Canada Joint Certification Program certification. Additionally, the contract incorporates FAR 52.222-90 regarding DEI discrimination and clarifies that while Cybersecurity Maturity Model Certification Level 2 is not required for the initial award, it may be necessary for future continued performance. Price is the sole evaluated factor for award.
All Other Plastics Product Manufacturing

POSTED

about 11 hours ago

DEADLINE

in 15 days
View Details
NAICS: 325412
New
Federal
Atropine Auto-Injector
Solicitation # SPE2DP-27-R-ATRO
DLA Troop Support is conducting market research via a sources sought notice for the procurement of Atropine Auto-Injectors under solicitation SPE2DP-27-ATRO. The agency intends to award a firm-fixed price, indefinite delivery, indefinite quantity contract consisting of a one-year base term and four one-year option terms. The required devices must deliver 1.67 mg of atropine base (equivalent to 2 mg atropine sulfate) and be 99.5 percent reliable, with a dispensing time of 0.5 seconds and an activation force between 0.90 and 3.60 kg. All products must be FDA approved per NDA No. 212319, comply with USP sterility standards, and maintain a minimum shelf life of 24 months upon delivery to DLA Distribution Susquehanna in New Cumberland, Pennsylvania. Strict packaging and marking requirements are mandated, including individual sealed polyethylene bags, intermediate boxes of 40 units, and exterior containers of 480 units, all conforming to MIL-STD-2073-1 and ASTM D4169-16. Labels must include specific dosage, storage, and usage instructions for nerve agent and insecticide poisoning. Interested respondents must provide their CAGE code, business size under NAICS 325412, and certification of commerciality per FAR 2.101. Manufacturers must submit FDA registration, while authorized distributors must provide a letter of commitment from the manufacturer. Responses are due by December 1, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

about 11 hours ago

DEADLINE

in about 1 month
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS